Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke: Sex difference in japanese

Kobe Journal of Medical Sciences

Volumn 47, Issue 6, 2001, Pages 255-262

  Wu, Yuan ^a   Tomon, Miyo ^a   Sumino, Kimiaki ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Homocysteine; Ischemic stroke; MTHFR; Polymorphism; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GENOMIC DNA; HOMOCYSTEINE;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DNA DETERMINATION; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; SEX DIFFERENCE; STROKE;

AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS;

EID: 0035742556     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III
2. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction
3. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction
4. Hyperhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors
5. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
6. Hyperhomocysteinemia: An independent risk factor for vascular disease
7. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke
8. Elevated total plasma homocysteine and 677C-T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease
9. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
10. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
11. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
12. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation
13. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification
14. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≤ 40 mu mol/liter) - The Hordaland homocysteine study
15. Genetic analysis of the thermolabile variant of 5,10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke
16. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
17. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
18. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
19. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects
20. C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: A case-control study
21. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US Physicians
22. Homocysteine and arterial occlusive diseases
23. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes
24. Inherited prothrombotic conditions and premature ischemic stroke: Sex difference in the association with factor V Leiden
25. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease
26. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese Arterioscler
27. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease
28. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease
29. Methylenetetrahydrofolate reductase mutation and coronary artery disease
30. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease
31. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study
32. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
33. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy
34. A prospective study of plasma homocysteine and risk of ischemic stroke
35. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population